TY - JOUR
T1 - Regulation of pyruvate dehydrogenase kinase 4 in the heart through degradation by the lon protease in response to mitochondrial substrate availability
AU - Crewe, Clair
AU - Schafer, Christopher
AU - Lee, Irene
AU - Kinter, Michael
AU - Szweda, Luke I.
N1 - Publisher Copyright:
©2017 by The American Society for Biochemistry and Molecular Biology, Inc.
PY - 2017/1/6
Y1 - 2017/1/6
N2 - Cardiac metabolic inflexibility is driven by robust up-regulation of pyruvate dehydrogenase kinase 4 (PDK4) and phosphorylation- dependent inhibition of pyruvate dehydrogenase (PDH) within a single day of feeding mice a high fat diet. In the current study, we have discovered that PDK4 is a short lived protein (t1/2 ∼ 1h) and is specifically degraded by the mitochondrial protease Lon. Lon does not rapidly degrade PDK1 and -2, indicating specificity toward the PDK isoform that is a potent modulator of metabolic flexibility. Moreover, PDK4 degradation appears regulated by dissociation from the PDH complex dependent on the respiratory state and energetic substrate availability of mouse heart mitochondria. Finally, we demonstrate that pharmacologic inhibition of PDK4 promotes PDK4 degradation in vitro and in vivo. These findings reveal a novel strategy to manipulate PDH activity by selectively targeting PDK4 content through dissociation and proteolysis.
AB - Cardiac metabolic inflexibility is driven by robust up-regulation of pyruvate dehydrogenase kinase 4 (PDK4) and phosphorylation- dependent inhibition of pyruvate dehydrogenase (PDH) within a single day of feeding mice a high fat diet. In the current study, we have discovered that PDK4 is a short lived protein (t1/2 ∼ 1h) and is specifically degraded by the mitochondrial protease Lon. Lon does not rapidly degrade PDK1 and -2, indicating specificity toward the PDK isoform that is a potent modulator of metabolic flexibility. Moreover, PDK4 degradation appears regulated by dissociation from the PDH complex dependent on the respiratory state and energetic substrate availability of mouse heart mitochondria. Finally, we demonstrate that pharmacologic inhibition of PDK4 promotes PDK4 degradation in vitro and in vivo. These findings reveal a novel strategy to manipulate PDH activity by selectively targeting PDK4 content through dissociation and proteolysis.
UR - http://www.scopus.com/inward/record.url?scp=85009394764&partnerID=8YFLogxK
U2 - 10.1074/jbc.M116.754127
DO - 10.1074/jbc.M116.754127
M3 - Article
C2 - 27856638
AN - SCOPUS:85009394764
SN - 0021-9258
VL - 292
SP - 305
EP - 312
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 1
ER -